Workflow
PROCEPT BioRobotics (PRCT)
icon
Search documents
PROCEPT BioRobotics (PRCT) - 2023 Q1 - Earnings Call Transcript
2023-04-30 13:31
Start Time: 08:00 January 1, 0000 8:56 AM ET PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2023 Earnings Conference Call April 27, 2023, 08:00 AM ET Company Participants Reza Zadno - President and CEO Kevin Waters - EVP and CFO Matt Bacso - VP, IR and Business Operations Conference Call Participants Craig Bijou - Bank of America Joshua Jennings - Cowen Ryan Zimmerman - BTIG Chris Pasquale - Nephron Research Neil Chatterji - B. Riley Richard Newitter - Truist Nathan Treybeck - Wells Fargo Matthew Mishan - ...
PROCEPT BioRobotics (PRCT) - 2022 Q4 - Earnings Call Transcript
2023-03-01 15:25
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2022 Results Conference Call February 28, 2023 4:30 PM ET Company Participants Matt Bacso - Vice President-Investor Relations Reza Zadno - Chief Executive Officer Kevin Waters - Senior Vice President and Chief Financial Office Conference Call Participants Joshua Jennings - Cowen Craig Bijou - Bank of America Chris Pasquale - Nephron Richard Newitter - Truist Neil Chatterji - B. Riley Nathan Treybeck - Wells Fargo Matthew Mishan - KeyBanc Ryan Zimmerman - BTIG ...
PROCEPT BioRobotics (PRCT) - 2022 Q4 - Annual Report
2023-02-28 21:11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-K ___________________________________ (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 ___________________ ...
Procept Biorobotics (PRCT) Investor Presentation - Slideshow
2022-11-10 04:31
1 VISION: THE BPH TREATMENT OF CHOICE FOR ALL PROSTATES November 2022 C o p y r i g h t 2 0 2 2 P R O C E P T B i o R o b o t i c s C o r p o r a t i o n . A l l R i g h t s R e s e r v e d . Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the expected financial results of PROCEPT BioRobotics Corporation (the "Company"). Words such as "anticipates," "believes," "expects," "intends," "projects, ...
PROCEPT BioRobotics (PRCT) - 2022 Q3 - Earnings Call Transcript
2022-11-06 13:22
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Bacso – Vice President-Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Senior Vice President and Chief Financial Office Conference Call Participants Craig Bijou – BofA Securities Nathan Treybeck – Wells Fargo Richard Newitter – Truist Securities Ryan Zimmerman – BTIG Neil Chatterji – B. Riley Matthew Mishan – KeyBanc Philip Coover – Goldman Sachs Jo ...
PROCEPT BioRobotics (PRCT) - 2022 Q3 - Quarterly Report
2022-11-04 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40797 PROCEPT BioRobotics Corporation (Exact name of registrant as specified in its charter) | Delaware | | | 26-0199180 | | ...
PROCEPT BioRobotics (PRCT) - 2022 Q3 - Earnings Call Presentation
2022-11-03 23:10
1 VISION: THE BPH TREATMENT OF CHOICE FOR ALL PROSTATES November 2022 C o p y r i g h t 2 0 2 2 P R O C E P T B i o R o b o t i c s C o r p o r a t i o n . A l l R i g h t s R e s e r v e d . Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the expected financial results of PROCEPT BioRobotics Corporation (the "Company"). Words such as "anticipates," "believes," "expects," "intends," "projects, ...
PROCEPT BioRobotics (PRCT) - 2022 Q2 - Earnings Call Transcript
2022-08-07 04:19
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Matt Bacso - Investor Relations Reza Zadno - Chief Executive Officer Kevin Waters - Chief Financial Officer Conference Call Participants Joshua Jennings - Cowen Craig Bijou - Bank of America Amit Hazan - Goldman Sachs Matthew Mishan - KeyBanc Neil Chatterji - B. Riley Operator Good afternoon, and welcome to PROCEPT BioRobotics Second Quarter Earnings Conference Call. At this time, al ...
PROCEPT BioRobotics (PRCT) - 2022 Q2 - Quarterly Report
2022-08-05 20:05
Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from to Commission file number 001-40797 PROCEPT BioRobotics Corporation (Exact name of registrant as specified in its charter) | Delaware | | | 26-0199180 | | --- | --- | --- | --- | | (State or other jurisdiction of incorporation or | | | (I.R.S. Employ ...
PROCEPT BioRobotics (PRCT) - 2022 Q1 - Earnings Call Transcript
2022-05-08 07:12
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Matt Bacso - Investor Relations Reza Zadno - Chief Executive Officer Kevin Waters - Chief Financial Officer Conference Call Participants Josh Jennings - Cowen Craig Bijou - Bank of America Amit Hazan - Goldman Sachs Matt Bacso Thanks, operator. Good afternoon and thank you for participating in today’s call. Joining me from PROCEPT BioRobotics are Reza Zadno, CEO and Kevin Waters, CFO. E ...